91 related articles for article (PubMed ID: 21192905)
1. [Photodynamic therapy with verteporfirin in corneal neovascularization].
Verdiguel-Sotelo K; Hernández-López A; González-Camarena PI; Devereux-García R; Pineda-Espinosa MS; Gómez-Dávila R
Rev Med Inst Mex Seguro Soc; 2010; 48(3):313-6. PubMed ID: 21192905
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin for corneal neovascularization.
Yoon KC; You IC; Kang IS; Im SK; Ahn JK; Park YG; Ahn KY
Am J Ophthalmol; 2007 Sep; 144(3):390-395. PubMed ID: 17631268
[TBL] [Abstract][Full Text] [Related]
3. [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].
Hamdan J; Boulze M; Aziz A; Alessi G; Hoffart L
J Fr Ophtalmol; 2015 Dec; 38(10):924-33. PubMed ID: 26522892
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
You IC; Im SK; Lee SH; Yoon KC
Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
[TBL] [Abstract][Full Text] [Related]
5. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin.
Al-Abdullah AA; Al-Assiri A
Optometry; 2011 Apr; 82(4):212-4. PubMed ID: 21216676
[TBL] [Abstract][Full Text] [Related]
6. [Neovascularization corneal regression in patients treated with photodynamic therapy with verteporfin].
Díaz-Dávalos CD; Carrasco-Quiroz A; Rivera-Díez D
Rev Med Inst Mex Seguro Soc; 2016; 54(2):164-9. PubMed ID: 26960043
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of corneal neovascularization with verteporfin.
Fossarello M; Peiretti E; Zucca I; Serra A
Cornea; 2003 Jul; 22(5):485-8. PubMed ID: 12827058
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with verteporfin for corneal neovascularization.
Al-Torbak AA
Middle East Afr J Ophthalmol; 2012; 19(2):185-9. PubMed ID: 22623856
[TBL] [Abstract][Full Text] [Related]
10. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.
Yoon KC; Ahn KY; Lee SE; Kim KK; Im SK; Oh HJ; Jeong IY; Park SW; Park YG; Nah HJ; Im WB
Curr Eye Res; 2006 Mar; 31(3):215-24. PubMed ID: 16531278
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
12. Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.
Kim RY; Chung SK; Kim MS; Ra H
Cornea; 2016 Dec; 35(12):1615-1620. PubMed ID: 27684458
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
Gohto Y; Obana A; Kanai M; Nagata S; Miki T; Nakajima S
Ophthalmic Surg Lasers; 2000; 31(1):55-60. PubMed ID: 10976562
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.
Ju M; Mailhos C; Bradley J; Dowie T; Ganley M; Cook G; Calias P; Lange N; Adamis AP; Shima DT; Robinson GS
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):662-70. PubMed ID: 18235012
[TBL] [Abstract][Full Text] [Related]
15. Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.
Sheppard JD; Epstein RJ; Lattanzio FA; Marcantonio D; Williams PB
Am J Ophthalmol; 2006 Mar; 141(3):524-529. PubMed ID: 16490500
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protein change and oxidative stress index after photodynamic therapy of corneal neovascularization.
Abdelkawi SA; Hassan AA
Gen Physiol Biophys; 2012 Dec; 31(4):449-55. PubMed ID: 23255672
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins.
Sugisaki K; Usui T; Nishiyama N; Jang WD; Yanagi Y; Yamagami S; Amano S; Kataoka K
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):894-9. PubMed ID: 18326709
[TBL] [Abstract][Full Text] [Related]
18. Regression of mature lymphatic vessels in the cornea by photodynamic therapy.
Bucher F; Bi Y; Gehlsen U; Hos D; Cursiefen C; Bock F
Br J Ophthalmol; 2014 Mar; 98(3):391-5. PubMed ID: 24414403
[TBL] [Abstract][Full Text] [Related]
19. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
20. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
Yoon KC; Im SK; Park HY
Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
